Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy

Zhifu Chen, Yan Wang, Jun Chen, Zijun Xu, Tingjuan Zhang, Lu Sun, Lihua Zhu, Liben Xu, Chaoyang Wu, Zhiyuan Qiu, Dianjun Wang, Ting Wu · 2025

Read Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy by Zhifu Chen, Yan Wang, Jun Chen, Zijun Xu, Tingjuan Zhang, Lu Sun, Lihua Zhu, Liben Xu, Chaoyang Wu, Zhiyuan Qiu, Dianjun Wang, Ting Wu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11782036.txt.

Description

Esophageal cancer patients get chemotherapy and radiation before surgery, and how much the tumor shrinks forecasts their outlook. Zhifu Chen and eleven co-authors hunted for blood or tissue markers of that shrinkage in a 2024 study of 60 patients. They compared tumor regression grades against patient features and survival, and mined public gene data from before and after treatment.

A third of patients saw the tumor vanish entirely under the microscope, and three fifths responded strongly. Poorly differentiated tumors and invasion into nerves or vessels predicted weak shrinkage, and weaker shrinkage meant shorter survival. Three candidate genes emerged, with protein checks tying them to outcomes.

Catalog record

CREATORZhifu Chen, Yan Wang, Jun Chen, Zijun Xu, Tingjuan Zhang, Lu Sun, Lihua Zhu, Liben Xu, Chaoyang Wu, Zhiyuan Qiu, Dianjun Wang, Ting Wu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11782036

Browse the full library · About the Tower of Babel